Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Rejuvel Bio Sciences Inc (EM) NUUU

Rejuvel Bio-Sciences, Inc., a development stage company, produces, distributes, markets, and sells skin care products worldwide. The company primarily offers skin cream under the Rejuvel brand. It also intends to develop, build, and sell environmental management solutions that use electron particle accelerator technology for the treatment of drinking water, municipal and industrial wastewater, sludge, and produced water from oil and gas fracturing activities. The company was formerly known as Technology Applications International Corporation and changed its name to Rejuvel Bio-Sciences, Inc. in June 2015. Rejuvel Bio-Sciences, Inc. was founded in 2009 and is headquartered in Miami, Florida.


EXPM:NUUU - Post by User

User Avatar Image
(0)
•••
  • qualitystocks.netX
Post by qualitystocks.neton Oct 16, 2014 4:44pm
148 Views
Post# 23035698

Technology Applications International Corp. (NUUU) Delivers

Technology Applications International Corp. (NUUU) Delivers
Technology Applications International Corp. (NUUU) Delivers Territory Exclusivity to Meditem Cyprus Limited
 
Technology Applications International Corp. has announced that wholly owned subsidiary Rejuvel Int’l, Inc. signed an agreement with Olgun Emirzade, Director of Meditem Cyprus Limited, naming Northern Cyprus a protected distribution territory for Meditem. The terms of the agreement call for Meditem to buy from Rejuvel at least $9,000 USD of product each month. Meditem has made a local television advertising buy along with print and digital advertising, billboards and vehicle wraps.
 
NUUU’s CEO Charles J. Scimeca, commented, “Considering that the total population of Northern Cypress is just under 300,000, the commitment from Meditem is significant. We welcome their company to our growing distribution network.”
 
Issuer Direct-Technology Applications International Corporation operates two wholly owned subsidiaries, Rejuvel Int’l, Inc. and NueEarth, Inc. NUUU’s Rejuvel Int’l, Inc. is rolling out its REJUVEL brand of breakthrough technologically – its 3-D stem cell extract anti-aging product made in partnership with NASA within an exclusive agreement.
 
REJUVEL anti-aging products are created in ‘simulated microgravity,’ in NASA bioreactors, and promote the body’s organic healing mechanisms. The company’s products are considered to be “Space Certified” and are recognized as technology that has been developed in outer space. The Space Foundation Seal will be affixed on all of their products.
 
NUUU’s NueEarth, Inc. subsidiary centers its work on the development of solutions using electron particle beam technology (E-Beam). The E-Beam works by using an electron beam particle accelerator unit which is proven to create high-energy electrons. These electrons produce free radicals which cause organic compounds to decompose. NUUU has plans to create a variety of applications to use the E-Beam technology for removal of pollutants from drinking water, wastewater, municipal sludge and fracking liquids.
 
The company has to update its shareholders and the public on company developments through additional press releases as events warrant.
 
For more information on the company, visit https://tapplic.com
 
Please see disclaimer on the QualityStocks website: https://Disclaimer.QualityStocks.com
<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities